Features

» cancer and funding

Most Recent

image: Freezing Time

Freezing Time

By | May 1, 2012

Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.

15 Comments

image: Telomeres in Disease

Telomeres in Disease

By | May 1, 2012

Telomeres have been linked to numerous diseases over the years, but how exactly short telomeres cause diseases and how medicine can prevent telomere erosion are still up for debate.

16 Comments

image: Are Cancer Stem Cells Ready for Prime Time?

Are Cancer Stem Cells Ready for Prime Time?

By | April 1, 2012

A flood of new discoveries has refined our definition of cancer stem cells. Now it’s up to human clinical trials to test if they can make a difference in patients.

48 Comments

image: What it Takes to Develop Better Drugs for Kids

What it Takes to Develop Better Drugs for Kids

By | March 1, 2012

Over the past 15 years, new laws and regulations in the United States and the European Union have expanded to require the inclusion of pediatric patients in clinical drug trials.  

2 Comments

image: Are the Kids Alright?

Are the Kids Alright?

By | March 1, 2012

Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?

6 Comments

image: Vitamin D on Trial

Vitamin D on Trial

By | March 1, 2012

Prevention trials for vitamins and supplements are notoriously difficult, but some researchers aren’t giving up on finding proof that vitamin D helps ward off disease.

52 Comments

image: Life Sciences Salary Survey 2011

Life Sciences Salary Survey 2011

By | December 1, 2011

US salaries are starting to recover after last year’s survey recorded the first-ever drop.

18 Comments

image: Funding

Funding

By and | October 1, 2011

Explore the past and present of US research funding, compare the investment priorities of the United States and Europe, and read an opinion from Research!America president Mary Woolley on what scientists need to do to secure the financial future of the US research enterprise.

0 Comments

image: A Small Revolution

A Small Revolution

By | October 1, 2011

In fewer than 15 years, nanomedicine has gone from fantasy to reality.

0 Comments

image: Nanomedicine

Nanomedicine

October 1, 2011

At the nanoscale old materials acquire new properties that International Institute for Nanotechnology Director Chad Mirkin thinks will change the way medicine is practiced.

0 Comments

Advertisement

Popular Now

  1. Opinion: Making Progress by Slowing Down
  2. Influential Cancer Biologist Dies
  3. Censored Professor Quits
    The Nutshell Censored Professor Quits

    Alice Dreger is resigning from the faculty of Northwestern University, claiming that the administration censored her work in a faculty journal.

  4. How Fats Influence the Microbiome
Advertisement
Advertisement
Life Technologies